An adhesion is a band of scar tissue binding tissue or organ parts together. It develops as a repair mechanism to different types of disruptions in the body including surgery. Adhesions from surgery can cause mild to severe medical complications. The potential market size for this is $550 million.
NovelMed is developing a gel to reduce adhesions after surgery. Proof of concept studies have been completed as well as proof of efficacy in animal models of adhesions. NovelMed is looking for investment to advance its NIH funded program to next level.
NovelMed is currently seeking pharma/venture partners to develop its portfolio of unique therapies for orphan & non-orphan indications.